209 related articles for article (PubMed ID: 15056846)
1. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as next-generation antisense and antigene agents.
Koizumi M
Biol Pharm Bull; 2004 Apr; 27(4):453-6. PubMed ID: 15056846
[TBL] [Abstract][Full Text] [Related]
2. ENA oligonucleotides as therapeutics.
Koizumi M
Curr Opin Mol Ther; 2006 Apr; 8(2):144-9. PubMed ID: 16610767
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and properties of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides.
Morita K; Takagi M; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
Bioorg Med Chem; 2003 May; 11(10):2211-26. PubMed ID: 12713831
[TBL] [Abstract][Full Text] [Related]
4. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) with nuclease-resistance and high affinity for RNA.
Morita K; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
Nucleic Acids Res Suppl; 2001; (1):241-2. PubMed ID: 12836354
[TBL] [Abstract][Full Text] [Related]
5. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA): highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug.
Morita K; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
Bioorg Med Chem Lett; 2002 Jan; 12(1):73-6. PubMed ID: 11738576
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the inhibitory activity of oatp antisense oligonucleotides by incorporation of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) without a loss of subtype selectivity.
Takagi M; Morita K; Nakai D; Nakagomi R; Tokui T; Koizumi M
Biochemistry; 2004 Apr; 43(15):4501-10. PubMed ID: 15078096
[TBL] [Abstract][Full Text] [Related]
7. Conformationally constrained 2'-N,4'-C-ethylene-bridged thymidine (aza-ENA-T): synthesis, structure, physical, and biochemical studies of aza-ENA-T-modified oligonucleotides.
Varghese OP; Barman J; Pathmasiri W; Plashkevych O; Honcharenko D; Chattopadhyaya J
J Am Chem Soc; 2006 Nov; 128(47):15173-87. PubMed ID: 17117869
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of oatp subtype-specific antisense oligonucleotides having 2'-O,4'-C-ethylene-bridged nucleic acids (ENA).
Takagi M; Morita K; Nakai D; Nakagomi R; Tokui T; Koizumi M
Nucleic Acids Res Suppl; 2003; (3):83-4. PubMed ID: 14510391
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of ENA Nucleotides and ENA Oligonucleotides.
Morita K; Koizumi M
Curr Protoc Nucleic Acid Chem; 2018 Mar; 72(1):4.79.1-4.79.21. PubMed ID: 29927121
[TBL] [Abstract][Full Text] [Related]
10. Triazole- and Tetrazole-Bridged Nucleic Acids: Synthesis, Duplex Stability, Nuclease Resistance, and in Vitro and in Vivo Antisense Potency.
Mitsuoka Y; Yamamoto T; Kugimiya A; Waki R; Wada F; Tahara S; Sawamura M; Noda M; Fujimura Y; Kato Y; Hari Y; Obika S
J Org Chem; 2017 Jan; 82(1):12-24. PubMed ID: 27936689
[TBL] [Abstract][Full Text] [Related]
11. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties.
Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J
J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352
[TBL] [Abstract][Full Text] [Related]
12. Comparison between properties of 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) phosphorothioate oligonucleotides and N3'-P5' thiophosphoramidate oligonucleotides.
Horie M; Morita K; Kawakami J; Ando O; Koizumi M; Tsutsumi S
Nucleosides Nucleotides Nucleic Acids; 2006 Mar; 25(3):231-42. PubMed ID: 16629117
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and properties of a bridged nucleic acid with a perhydro-1,2-oxazin-3-one ring.
Shrestha AR; Hari Y; Yahara A; Osawa T; Obika S
J Org Chem; 2011 Dec; 76(24):9891-9. PubMed ID: 22059648
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and properties of ENA oligonucleotides targeted to human telomerase RNA subunit.
Horie M; Morita K; Kawakami J; Tsutsumi S; Ando O; Koizumi M
Nucleic Acids Symp Ser (Oxf); 2005; (49):171-2. PubMed ID: 17150688
[TBL] [Abstract][Full Text] [Related]
15. Effect of ENA modification of triplex-forming oligonucleotide on pyrimidine motif triplex formation.
Torigoe H; Nagasawa N
Nucleic Acids Symp Ser (Oxf); 2007; (51):161-2. PubMed ID: 18029636
[TBL] [Abstract][Full Text] [Related]
16. Chimeric RNA and 2'-O, 4'-C-ethylene-bridged nucleic acids have stronger activity than phosphorothioate oligodeoxynucleotides in induction of exon 19 skipping in dystrophin mRNA.
Yagi M; Takeshima Y; Surono A; Takagi M; Koizumi M; Matsuo M
Oligonucleotides; 2004; 14(1):33-40. PubMed ID: 15104894
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Properties of the 5-Methyluridine Derivative of 3,4-Dihydro-2H-pyran-Bridged Nucleic Acid (DpNA).
Osawa T; Hari Y; Dohi M; Matsuda Y; Obika S
J Org Chem; 2015 Nov; 80(21):10474-81. PubMed ID: 26431393
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and properties of 2'-O,4'-C-spirocyclopropylene bridged nucleic acid (scpBNA), an analogue of 2',4'-BNA/LNA bearing a cyclopropane ring.
Yamaguchi T; Horiba M; Obika S
Chem Commun (Camb); 2015 Jun; 51(47):9737-40. PubMed ID: 25985928
[TBL] [Abstract][Full Text] [Related]
19. 2'-O,4'-C-methyleneoxymethylene bridged nucleic acids (2',4'-BNA(COC)).
Hari Y; Kodama T; Imanishi T; Obika S
Methods Mol Biol; 2011; 764():31-57. PubMed ID: 21748632
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of VEGF mRNA expression by 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) antisense oligonucleotides and investigation of non-target gene expression.
Morita K; Yamate K; Kurakata S; Abe K; Imanishi T; Koizumi M
Nucleic Acids Res Suppl; 2002; (2):99-100. PubMed ID: 12903124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
